Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
David Berry
AddedMar 31, 2024
UpdatedMay 31, 2026
David Berry

David Berry

Co-Founder, Seres Therapeutics

CrunchbaseLinkedIn

David Berry's Career

Seres Therapeutics
Seres Therapeutics

Cambridge, MA, US

Co-Founder
Valo Health
Valo Health

Boston, MA, US

Founder & CEO· C-Suite · Management
Inari Agriculture
Inari Agriculture

Cambridge, MA, US

Co-Founder
Indigo
Indigo

Boston, MA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

David Berry's Career

Seres Therapeutics
Seres Therapeutics
Public$537.8M4312010Cambridge, MA, US
Co-Founder

Leadership at Seres Therapeutics

Noubar AfeyanNoubar AfeyanCo-Founder
Roger PomerantzRoger PomerantzBoard Member
Willard DereWillard DereBoard Member
Meryl ZausnerMeryl ZausnerBoard Member
Greg BeharGreg BeharBoard Member
Eric ShaffEric ShaffCEO

Similar to Seres Therapeutics

Microbiome TherapeuticsMicrobiome TherapeuticsBroomfield, CO, USMedical Researchest. 2009Microbiome TherapeuticsBroomfield, CO, US · est. 2009

Microbiome Therapeutics LLC: A US-based medical research firm specializing in metabolic disease solutions.

Series B · $3M30
Petri BioPetri BioLos Angeles, CA, USTherapeuticsest. 2019Petri BioLos Angeles, CA, US · est. 2019

Petri Bio: A biotech firm innovating gut microbe-based therapeutics.

Seed · $255k3
Solarea BioSolarea BioCambridge, MA, USBiotechnology, Therapeuticsest. 2017Solarea BioCambridge, MA, US · est. 2017

Solarea Bio, a Cambridge-based biotech firm, innovates microbiome solutions for global health issues.

Series B · $26.2M24
DermBiontDermBiontBoston, MA, USTherapeuticsest. 2017DermBiontBoston, MA, US · est. 2017

DermBiont: A leading precision dermatology firm, developing targeted therapeutics for skin health.

Series B · $108.5M47
Valo Health
Valo Health
Series C$460M1682019Boston, MA, US
Founder & CEO· C-Suite · Management

Leadership at Valo Health

David R EpsteinDavid R EpsteinBoard Member
Paul BiondiPaul BiondiBoard Member
Harsha RamalingamHarsha RamalingamBoard Member
Ron HovsepianRon HovsepianBoard Member
David BerryDavid BerryBoard Member
Adam SmalleyAdam SmalleyBoard Member

Similar to Valo Health

Valera HealthValera HealthNew York, USMental Health, Telehealthest. 2015Valera HealthNew York, US · est. 2015

Valera: A tech-driven tele-mental health firm, focusing on BIPOC and LGBTQ+ communities.

Series D · $71.9M344
Vesalius TherapeuticsVesalius TherapeuticsCambridge, MA, USDrug Developmentest. 2019Vesalius TherapeuticsCambridge, MA, US · est. 2019

Vesalius Therapeutics: Innovating drug development to combat major human illnesses.

Series A · $75M35
Valhalla HealthcareValhalla HealthcareHouston, TX, USHealthcareest. 2017Valhalla HealthcareHouston, TX, US · est. 2017

Healthcare tech firm using AI and ML to provide affordable, accessible, and effective care.

Seed · $100k6
Valorant HealthValorant HealthBerkeley, CA, USDigital Health, Healthcareest. 2019Valorant HealthBerkeley, CA, US · est. 2019

AI-enabled digital health system, bridging healthcare access for underserved US communities.

Pre-Seed · $1.3M14
Inari Agriculture
Inari Agriculture
Series F$609M4652016Cambridge, MA, US
Co-Founder

Leadership at Inari Agriculture

Ignacio MartinezIgnacio MartinezCo-Founder & CEO
Sophie VandebroekSophie VandebroekBoard Member
George ChurchGeorge ChurchBoard Member
Michael MackMichael MackBoard Member
Ponsi TrivisvavetPonsi TrivisvavetBoard Member
Rodolphe BarrangouRodolphe BarrangouBoard Member

Similar to Inari Agriculture

IndigoIndigoBoston, MA, USAgricultural Productsest. 2013IndigoBoston, MA, US · est. 2013

Based in Boston, Indigo Agriculture, Inc. enhances agricultural production globally through microbial and digital technologies.

Late Stage Private · $1.4B1.7k
Sound AgricultureSound AgricultureEmeryville, CA, USCrop Solutionsest. 2012Sound AgricultureEmeryville, CA, US · est. 2012

Sound Agriculture: Innovating crop solutions for climate-resilient farming and enhanced yields, US-based.

Series D · $170.4M168
Pairwise PlantsPairwise PlantsDurham, NC, USCrop Developmentest. 2017Pairwise PlantsDurham, NC, US · est. 2017

Pairwise Plants, LLC: A global agricultural firm specializing in developing new crop varieties.

Series B · $115M75
VoloAgri GroupVoloAgri GroupSouth San Francisco, CA, USAgriculture, Seedest. 2012VoloAgri GroupSouth San Francisco, CA, US · est. 2012

VoloAgri Group Inc.: Nationwide provider of management and financing solutions for agricultural companies.

Series A · $127M200
Indigo
Indigo
Late Stage Private$1.4B1.7k2013Boston, MA, US
Co-Founder

Leadership at Indigo

David PerryDavid PerryBoard Member
John GehringJohn GehringBoard Member
Peter InnesPeter InnesBoard Member
Ann SimondsAnn SimondsBoard Member
Geoffrey von MaltzahnGeoffrey von MaltzahnBoard Member
Deborah WinshelDeborah WinshelBoard Member

Similar to Indigo

CortevaCortevaIndianapolis, IN, USCrop Protection, Seedest. 2019CortevaIndianapolis, IN, US · est. 2019

Corteva Agriscience, an American agriculture company, innovatively delivers solutions for global agriculture challenges, maximizing farmer productivity.

Public21k
Advancing Eco AgricultureAdvancing Eco AgricultureMiddlefield, OH, USAgriculture, Productsest. 2006Advancing Eco AgricultureMiddlefield, OH, US · est. 2006

Advancing Eco Agriculture: Balancing yield inputs for regenerative agriculture systems.

Series A · $4.7M68
Sound AgricultureSound AgricultureEmeryville, CA, USCrop Solutionsest. 2012Sound AgricultureEmeryville, CA, US · est. 2012

Sound Agriculture: Innovating crop solutions for climate-resilient farming and enhanced yields, US-based.

Series D · $170.4M168
Pivot BioPivot BioBerkeley, CA, USAgricultural Productsest. 2010Pivot BioBerkeley, CA, US · est. 2010

Pivot Bio, Inc.: A US-based AgriTech firm innovating plant nutrition by harnessing atmospheric nitrogen.

Series D · $616.9M488

David Berry's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · Kakao

People Similar to David Berry

David LightDavid LightFounder · Pallasite VenturesNikhil JainNikhil JainCo-Founder · ObENJames NahirnyJames NahirnyFounder · Alsora CapitalGuy PistoneGuy PistoneFounder · FitivityDrew ReidDrew ReidFounder · Maple Materials